These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 28319052)

  • 1. A "tail" of opioid receptor variants.
    Puig S; Gutstein HB
    J Clin Invest; 2017 Apr; 127(4):1221-1224. PubMed ID: 28319052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement of current opioid drugs focusing on MOR-related strategies.
    Busserolles J; Lolignier S; Kerckhove N; Bertin C; Authier N; Eschalier A
    Pharmacol Ther; 2020 Jun; 210():107519. PubMed ID: 32165137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-type specific molecular architecture for mu opioid receptor function in pain and addiction circuits.
    Ochandarena NE; Niehaus JK; Tassou A; Scherrer G
    Neuropharmacology; 2023 Nov; 238():109597. PubMed ID: 37271281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mu Opioid Pharmacology: 40 Years to the Promised Land.
    Pasternak GW
    Adv Pharmacol; 2018; 82():261-291. PubMed ID: 29413524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current strategies toward safer mu opioid receptor drugs for pain management.
    Ehrlich AT; Kieffer BL; Darcq E
    Expert Opin Ther Targets; 2019 Apr; 23(4):315-326. PubMed ID: 30802415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Truncated mu opioid GPCR variant involvement in opioid-dependent and opioid-independent pain modulatory systems within the CNS.
    Marrone GF; Grinnell SG; Lu Z; Rossi GC; Le Rouzic V; Xu J; Majumdar S; Pan YX; Pasternak GW
    Proc Natl Acad Sci U S A; 2016 Mar; 113(13):3663-8. PubMed ID: 26976581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examining the role of mu opioid receptor endocytosis in the beneficial and side-effects of prolonged opioid use: from a symposium on new concepts in mu-opioid pharmacology.
    Whistler JL
    Drug Alcohol Depend; 2012 Mar; 121(3):189-204. PubMed ID: 22226706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Truncated Six Transmembrane Splice Variant MOR-1G Enhances Expression of the Full-Length Seven Transmembrane
    Zhang T; Xu J; Pan YX
    Mol Pharmacol; 2020 Oct; 98(4):518-527. PubMed ID: 32723770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tetrapeptide Endomorphin Analogs Require Both Full Length and Truncated Splice Variants of the Mu Opioid Receptor Gene Oprm1 for Analgesia.
    Marrone GF; Lu Z; Rossi G; Narayan A; Hunkele A; Marx S; Xu J; Pintar J; Majumdar S; Pan YX; Pasternak GW
    ACS Chem Neurosci; 2016 Dec; 7(12):1717-1727. PubMed ID: 27648914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor.
    Choi HS; Kim CS; Hwang CK; Song KY; Wang W; Qiu Y; Law PY; Wei LN; Loh HH
    Biochem Biophys Res Commun; 2006 May; 343(4):1132-40. PubMed ID: 16580639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent Progress in Opioid Research from an Electrophysiological Perspective.
    Birdsong WT; Williams JT
    Mol Pharmacol; 2020 Oct; 98(4):401-409. PubMed ID: 32198208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncated G protein-coupled mu opioid receptor MOR-1 splice variants are targets for highly potent opioid analgesics lacking side effects.
    Majumdar S; Grinnell S; Le Rouzic V; Burgman M; Polikar L; Ansonoff M; Pintar J; Pan YX; Pasternak GW
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):19778-83. PubMed ID: 22106286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring Pharmacological Functions of Alternatively Spliced Variants of the Mu Opioid Receptor Gene,
    Kang W; Liu S; Xu J; Abrimian A; Malik AF; Chien R; Adaralegbe A; Amponsah A; Cartegni L; Pintar J; Pan YX
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new splice of life for the μ-opioid receptor.
    Iadarola MJ; Sapio MR; Mannes AJ
    J Clin Invest; 2015 Jul; 125(7):2558-61. PubMed ID: 26011639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of MOR-1 splice variants of the mouse mu opioid receptor gene Oprm.
    Bolan EA; Pan YX; Pasternak GW
    Synapse; 2004 Jan; 51(1):11-8. PubMed ID: 14579421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of five mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
    Doyle GA; Sheng XR; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
    Gene; 2007 Jun; 395(1-2):98-107. PubMed ID: 17398041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mediation of opioid analgesia by a truncated 6-transmembrane GPCR.
    Lu Z; Xu J; Rossi GC; Majumdar S; Pasternak GW; Pan YX
    J Clin Invest; 2015 Jul; 125(7):2626-30. PubMed ID: 26011641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of six new alternatively spliced variants of the human mu opioid receptor gene, Oprm.
    Pan L; Xu J; Yu R; Xu MM; Pan YX; Pasternak GW
    Neuroscience; 2005; 133(1):209-20. PubMed ID: 15893644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular insights into mu opioid pharmacology: From the clinic to the bench.
    Pasternak GW
    Clin J Pain; 2010 Jan; 26 Suppl 10(Suppl 10):S3-9. PubMed ID: 20026962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of mu opioid receptor splice variants mRNA in human blood lymphocytes: a peripheral marker for opioid addiction studies.
    Vousooghi N; Goodarzi A; Roushanzamir F; Sedaghati T; Zarrindast MR; Noori-Daloii MR
    Int Immunopharmacol; 2009 Jul; 9(7-8):1016-20. PubMed ID: 19272466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.